상세 보기
Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07
- Kim, Tae Min;
- Kim, Jung Sun;
- Lee, Gyeong-Won;
- Lee, Myung-Won;
- Youk, Jeonghwan;
- 외 6명
Citations
WEB OF SCIENCE
1- 제목
- Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07
- 저자
- Kim, Tae Min; Kim, Jung Sun; Lee, Gyeong-Won; Lee, Myung-Won; Youk, Jeonghwan; Lee, Hyun Jung; Lim, Sung-Nam; Kim, Soyeon; Jeon, Yoon Kyung; Park, Chul-Kee; Heo, Dae Seog
- 발행일
- 2024-11
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 144
- 페이지
- 3102 ~ 3103
- 언어
- ENG
- 출판사
- American Society of Hematology
- 발행국가
- 미국
- 분량
- 2 페이지
- ISSN
- E 1528-0020
P 0006-4971